Soochow University Nanohybrids Mitigate Glucocorticoid Bone Loss in Rats
Engineers developed a peptide-oligonucleotide platform to deliver miR-26a-5p directly to injured skeletal sites in animal models.
Researchers from Soochow University, Zhejiang University, and Nanyang Technological University have developed a pathology-adapted peptide-oligonucleotide nanohybrid (PON) designed to counteract glucocorticoid-induced bone loss (GIBL) 
doi.orgNature Communicationsdoi.orgOpen source ↗. Glucocorticoid exposure often triggers systematic osteopenia and osteonecrosis of the femoral head, presenting a clinical challenge due to the simultaneous deterioration of bone architecture and local microvasculature doi.orgNature Communicationsdoi.orgOpen source ↗. As reported in Nature Communications, the targeted modular delivery platform was engineered to deliver microRNA-26a-5p directly into injured osseous environments doi.orgNature Communicationsdoi.orgOpen source ↗.
Targeted Nanohybrid Architecture
The PON design incorporates several functional features, including molecular self-assembly, affinity for bone tissue, enzyme-triggered responsiveness, cell-penetrating capabilities, and endosomal-lysosomal escape mechanisms doi.orgNature Communicationsdoi.orgOpen source ↗. Together, these characteristics overcome traditional systemic transport barriers associated with oligonucleotide therapeutics, shielding the cargo and improving localization within glucocorticoid-damaged microenvironments doi.orgNature Communicationsdoi.orgOpen source ↗. Systemic distribution of native oligonucleotides typically suffers from rapid degradation and low target-tissue bioaccumulation, issues addressed by this integrated delivery system doi.orgNature Communicationsdoi.orgOpen source ↗.
Molecular Pathways and In Vivo Efficacy
Mechanistically, the targeted delivery of miR-26a-5p suppressed glycogen synthase kinase-3 beta (GSK-3β) expression and promoted the stabilization of hypoxia-inducible factor 1-alpha (HIF-1α) doi.orgNature Communicationsdoi.orgOpen source ↗. This dual effect sustained osteogenesis-angiogenesis coupling while reducing cellular apoptosis under glucocorticoid exposure doi.orgNature Communicationsdoi.orgOpen source ↗. In rat disease models, systemic administration of the nanohybrids protected against initial skeletal and vascular degradation and limited pathological progression in established conditions doi.orgNature Communicationsdoi.orgOpen source ↗.
